Strata Critical MedicalSRTA -2.63%70 PB Ratio is 1.62 as of Jun. 26, 2026, which is 29% above its 10-year median of 1.26. GuruFocus rates SRTA with a GF Score™ of 70/100 and a GF Value™ of $4.47 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Strata Critical Medical ranks better than 59.08% on this metric.
The historical rank and industry rank for Strata Critical Medical's PB Ratio or its related term are showing as below:
SRTA'
s PB Ratio Range Over the Past 10 Years
Min: 0.6 Med: 1.26 Max: 2.72
Current: 1.62
During the past 7 years, Strata Critical Medical's highest PB Ratio was 2.72. The lowest was 0.60. And the median was 1.26.
SRTA's PB Ratio is ranked better than 59.08% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs SRTA: 1.62
During the past 12 months, Strata Critical Medical's average Book Value Per Share Growth Rate was 21.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -5.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 27.70% per year.
During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of Strata Critical Medical was 92.20% per year. The lowest was -12.40% per year. And the median was -5.60% per year.
Back to Basics: PB Ratio
Strata Critical Medical (NAS:SRTA) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Strata Critical Medical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Critical Medical PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's PB Ratio distribution charts can be found below:
* The bar in red indicates where Strata Critical Medical's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Strata Critical Medical (SRTA) has a PB Ratio of 1.62 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Strata Critical Medical and its competitors. This is 29% above median its historical median of 1.26. Over the past decade, Strata Critical Medical's PB Ratio has ranged from 0.60 to 2.72. According to the industry distribution chart, Strata Critical Medical ranks #250 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 40.9%.
Is Strata Critical Medical's PB Ratio too high?
Strata Critical Medical's current PB Ratio of 1.62 is 29% above median its 10-year median of 1.26. Over the past 10 years, this metric has ranged from a low of 0.60 to a high of 2.72. The Healthcare Providers & Services industry median PB Ratio is 1.98. Strata Critical Medical's value of 1.62 is 18.2% below this industry median. Based on the distribution chart, Strata Critical Medical ranks #250 out of 611 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Strata Critical Medical has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's PB Ratio compare to TOI and GMRS?
According to the Healthcare Providers & Services industry distribution chart, Strata Critical Medical ranks #250 out of 611 companies for PB Ratio. This puts Strata Critical Medical in the upper half of its industry. The industry median PB Ratio is 1.98. Strata Critical Medical's value of 1.62 is 18.2% below this benchmark. Historically, Strata Critical Medical's own PB Ratio has ranged from 0.60 to 2.72 over the past decade. While the company's 10-year median is 1.26 vs. the industry median of 1.98, Strata Critical Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strata Critical Medical's current PB Ratio of 1.62 is 18.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Strata Critical Medical and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Critical Medical's current PB Ratio is 1.62, which is 29% above median its own 10-year median of 1.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Based on GuruFocus' analysis, Strata Critical Medical (SRTA) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.47, compared to a current price of $5.37 — trading 20% above its estimated fair value. The current PB Ratio is 1.62, which is 29% above median its 10-year median of 1.26 and 18.2% below the Healthcare Providers & Services industry median of 1.98. Strata Critical Medical's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Strata Critical Medical (SRTA), the current PB Ratio is 1.62 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Strata Critical Medical (SRTA) Overvalued in 2026?
Based on GuruFocus' analysis, Strata Critical Medical stock appears to be overvalued.
The current stock price of $5.37 is trading 20% above its estimated GF Value™ of $4.47.
GuruFocus considers Strata Critical Medical to be Modestly Overvalued.
Key valuation signals for SRTA:
PB Ratio: 1.62 (29% above median its 10-year median of 1.26)
GF Value™: $4.47 vs. price of $5.37 (20% above fair value)
Industry Position: 18.2% below the Healthcare Providers & Services median (#250 of 611)
No single metric tells the full story. See the SRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
70GF Score
Get the complete analysis for SRTA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTA has been successfully added to your 
